59.87MMarket Cap-857P/E (TTM)
3.1000High2.7100Low15.40KVolume2.7100Open2.7400Pre Close43.00KTurnover0.08%Turnover RatioLossP/E (Static)21.61MShares7.420052wk High1.34P/B53.66MFloat Cap1.010052wk Low--Dividend TTM19.37MShs Float309.6000Historical High--Div YieldTTM14.23%Amplitude1.0100Historical Low2.7920Avg Price1Lot Size
Aileron Therapeutics Stock Forum
NEWS
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
NEWS
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Aileron Therapeutics, Inc. announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in IPF. Low-dose LTI-03 showed reductions in profibrotic proteins, increased expression of biomarkers, and was well-tolerated. Positive trends were observed in seven out of eight biomarkers. Data from Cohort 2 is expec...
No comment yet